Literature DB >> 23658

[Tropical entomophthoromycoses].

H Fromentin, P Ravisse.   

Abstract

A review was made about human entomophthoromycosis observed in tropical areas due to fungi of the order Entomophthorales. Rhinophycomycosis is caused by Entomophthora coronata, a cosmopolitan fungus which is only pathogen in wet tropical and subtropical climates. The disease, a muco-cutaneous infection of the face, induces monstruous deformations. Basidiobolomycosis is caused by Basidiobolus meristosporus, a saprophyte of different amphibians and reptiles very often present in the family Agamidae. The disease interests the subcutaneous tissues and is mainly located at the trunk, shoulders and upper part of the limbs. The epidemiology, clinic and therapeutic were reported. Histopathological lesions and morphology of both fungi were studied. The etiology of the casual agents of these mycoses was discussed.

Entities:  

Mesh:

Year:  1977        PMID: 23658

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  5 in total

1.  Comparative antigenic studies of species of Basidiobolus and other medically important fungi.

Authors:  B G Yangco; A Nettlow; J I Okafor; J Park; D Te Strake
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

Review 2.  Human Pathogenic Entomophthorales.

Authors:  Raquel Vilela; Leonel Mendoza
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

Review 3.  Human Fungal Pathogens of Mucorales and Entomophthorales.

Authors:  Leonel Mendoza; Raquel Vilela; Kerstin Voelz; Ashraf S Ibrahim; Kerstin Voigt; Soo Chan Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

Review 4.  Zygomycetes in human disease.

Authors:  J A Ribes; C L Vanover-Sams; D J Baker
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 5.  Entomophthoromycosis due to Conidiobolus.

Authors:  H C Gugnani
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.